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Class I molecules of the major histocompatibility complex (MHC)are expressed 
on the  cell  surface as a  complex of two noncovalently associated units, a  40- 
45,000 dalton subunit called the heavy chain and an 11,000 dalton subunit called 
32 microglobulin (/32m)  (1).  In the mouse this appears to be true for molecules 
encoded in the Qa-Tla region as well as for molecules encoded by the K, D, or 
L loci (2, 3). In contrast to the 45,000 dalton class I chain, O2m is not integrated 
into  the  membrane.  Similarly,  it  is  believed  that  the  heavy chains  of class  I 
molecules are  not expressed  in  the absence  of/32m.  Evidence  for  this  comes 
primarily from the study of two cell lines. The Burkitt iymphoma line, Daudi, 
expresses neither class I  HLA antigens nor B2m on the cell surface (4).  In this 
cell  line  the  primary  defect  is  the  inability  to  synthesize  /32m,  as  shown  by 
biochemical studies and by somatic cell hybridization experiments in which the 
expression of Daudi HLA antigens could be rescued either by mouse or human 
fl2m, provided by the normal partner in the hybrid (4). Essentially the same kind 
of data have been obtained by Hyman and his collaborators (5, 6) using a somatic 
cell variant of the C3H (H-2 k) tbymoma, R 1. These studies led to the conclusion 
that class I  proteins have to be associated with 32m  for expression on the cell 
surface.  We report  here  on a  spontaneous  variant of the B6  lymphoma EL4, 
which in contrast to the wild-type cell line, expresses neither H-2K  b nor 32m but 
does express H-2D b, which can be detected by serological reactivity as well as by 
cytotoxic T  lymphocytes (CTL). 
Materials and Methods 
Antibodies.  The monoclonal antibodies to H-2 specificities and to 32m listed in Table 
I were obtained from various investigators. Rabbit anti-mouse 32m was a kind gift from 
Dr. E. Appella. 
Tumor Cell Lines.  The original EL4 cell line was isolated by Dr. Peter Gorer (7) in 
1945.  We  have examined two sublines:  EL4/NY,  which has  been  maintained in  our 
laboratory for several years, and EL4/Mar, which is a variant that arose in the laboratory 
of Dr.  P.  Golstein.  RDM-4  is an  AKR/J thymoma cell  line  maintained in  vitro and 
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TABLE  I 
Reactivity of Monoclonal Anti-H-2 and Anti-132m Antibodies on EL 4  /NY and EL 4  /Mar 
Y-3  EH-144  28-14-8  B22/249  H141]5l  Lym-11  Clone 23 
(K  b)  (K  h)  (D  b)  (D  b)  (D  b)  ~2m  b  ~m b 
EL4/NY  +++  +++  +++  +++  +++  +++  +++ 
EL4/Mar  -  -  +++  +++  +++  -  - 
Reactivity was assessed by microcytotoxicity using monoclonal antibodies at a  concentration of 1:100 and rabbit 
complement at a final dilution of 1:9, as previously described (9).  +++, 99% of cells dead after 60 rain incubation; 
-, 5% of cells dead after 60 rain incubation. Monoclonal antibodies were obtained as follows: B22/249 and H 141/ 
51, Dr. G. Hammerling; 28-14-8, Dr. T. Hansen; Y-3, Dr. S. Nathenson; Lyre-11, Dr. U. Hammerling; clone 23, 
Dr. F. W. Shen. 
expresses H-2k-encoded products. 
Cytotoxic T Cell Lines and Clones.  The  H-2KLspecific polyclonal T  cell line (KB5) of 
B10.BR origin and the cytotoxic T  lymphocyte (CTL) clones derived from it (KB5-B1 
and KBS-C20) were established and maintained as previously described (8). H-2DLspecific 
CTL clones (K4R-E and  K4R-G series) were derived in a  similar manner  using T  cells 
from B10.BR mice immunized  with B10.A (4R) spleen cells that  were restimulated  in 
vitro every 7 d with B10.A (4R) spleen cells and cloned by limiting dilution (8). 
Imraunoprecipitation and Electrophoresis of Radiolabeled Surface Molecules.  Labeling of 
cell surface molecules with 11~5 was performed by the lactoperoxidase-catalyzed reaction 
in the presence of hydrogen peroxide as described previously (9). After preclearing the 
membrane  lysate,  immunoprecipitates  were prepared  by adding  monoclonal  or  xeno- 
antibodies to mouse t32m, followed by a suspension of Staphylococcus aureus. The precipi- 
tates were subjected to electrophoresis on a 10-cm  15% acrylamide slab gel as described 
by Laemmli (10). 
Results 
Serological Analysis of H-2 and ~2m.  The  examination  of the cytotoxicity of 
several monocional  antibodies  for the two EL4  sublines  showed that  these two 
cell lines differed in the expression of cell surface molecules (Table I). The anti- 
K b (Y-3,  EH-144), anti-D b (28-14-8,  H-141/51),  and the two anti-132m (Lyre-11, 
clone  23) monoclonal  antibodies  were all  cytotoxic for EL4/NY,  whereas  only 
the anti-D b antibodies were cytotoxic for EL4/Mar.  The inability of anti-K b and 
anti-C/2m  antibodies  to  kill  EL4/Mar  was  also  observed  at  dilutions  of  the 
antibodies lower than  those presented in Table I. 
The  reactivity  of anti-H-2  and  anti-C/2m  antibodies  was  also  examined  by 
immunofluorescence  on the fluorescence-activated  cell sorter (FACS). The reac- 
tivity  observed  was  essentially  the  same  as  that  observed  in  microcytotoxicity 
testing. EL4/NY reacted with anti-K b (EH-144) (Fig.  1) anti-D b (28-14-8,  H-141 / 
51) (Fig.  1) and anti-Lyre-11  (Fig. 2) antibodies; on the other hand, only the anti- 
O b antibodies  (28-14-8,  H-141/51)  (Fig.  1) but not anti-K b (Fig.  1) or anti-Lym- 
11  (Fig.  2) antibodies  showed any reactivity with  EL4/Mar.  In addition,  it was 
apparent  that  the  level  of reactivity  of the  D b antibodies  with  EL4/Mar  was 
essentially the same as that seen with EL4/NY. Thus, by both serological criteria, 
microcytotoxicity  and  immunofluorescence,  EL4/NY  was  K b+  D b÷  Lym-11 
(~2m) + whereas EL4/Mar  was  g  b-  O b+ Lym-11-. 
lmmunoprecipitation  of ~2m from  Cell  Surfaces.  The  failure  of EL4/Mar  to 
react with the anti-Lym-11  antibody may have been due to a  mutation  resulting 
in the loss of allotypic specificity. To test this possibility, we immunoprecipitated 
/32m from lysates of cells labeled with  1125, using xenogeneic as well as allogeneic 
antibodies.  Precipitation  with  either  the  allotypic  antibodies,  Lym-11  or  clone 
23 (Fig.  3), or the xenogeneic  antibody  (rabbit  a-132m) (Fig.  3) to mouse ~2m, POTTER  ET  AL. 
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FLUORESCENCE  INTENSITY 
FIGURE  l.  Reactivity of anti-H-2 antibodies with EL4/NY and EL4/Mar measured on the 
FACS. The binding of the monoclonal alloantibodies  was detected with fluorescein isothio- 
cyanate-conjugated  goat anti-mouse immunoglobulin  antibody (FGAMIg), as previously de- 
scribed (9). Bkg, reactivity of FGAMIg alone. 
EL4/NY  Ek4/Mar 
i 
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FIGURE 2.  Reactivity of anti-~2m antibodies with EL4/NY and EL4/Mar measured on the 
FACS.  The  binding of the  monoclonal alloantibodies  was  detected  with  FGAMIg.  Bkg, 
reactivity of FGAMIg alone. 
brought down/~2m from EL4/NY but not from EL4/Mar lysates (Fig. 3). Since 
the  xenogeneic antibody  recognizes determinants  distinct  from  the  allotypic 
specificity on/~2m (e.g., this antibody can precipitate B2m from both C57BL/6 
and BALB/c cell lines), the failure to precipitate B2m from EL4/Mar using the 
xenoantiserum is strong evidence that this cell line does not express ~2m on the 
cell surface. 
Cell-mediated Cytotoxicity.  The reactivity of previously characterized (8) anti- 
K  b- and anti-Db-specific alloreactive CTL was also examined on the EL4 sub- 
lines. The anti-Kb-specific polyclonal (line KB5) or monoclonal (clones KB5.B1 
and C20) B10.BR CTL lysed EL4/NY but not EL4/Mar (Table II). By contrast, 320  POTTER  ET  AL.  BRIEF  DEFINITIVE REPORT 
FIGURE  3.  Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of mole- 
cules precipitated from EL4/NY and EL4/Mar. Membrane preparations labeled with I l*~ were 
precipitated with anti-/~2m antibodies, rabbit a-O2m or clone 23 (monoclonal anti-/~2m); 10-2- 
16 is a monoclonal anti-Ia reagent used as a negative control./32m runs slightly faster than the 
12,000  dalton marker and can be identified  in the third and fifth lanes only.  NRS, normal 
rabbit serum. 
TABLE  II 
H-2Db-specific, But Not H-2Kb-specific CTL Clones Lyse the EL4/Mar Tumor Target Cells 
A. Anti-K  b effector cells 
Effector cells* 
Percent  specific 5tCr release on target cells 
B6*  B10.A(4R)*  EL4/NY  EL4/Mar  RDM4 
CTL line KB5  75  7.5  80  3.6  NT  i 
Clone KB5-B1  70  7.1  98  -0.9  NT 
Clone KB5-C20  68  5.4  32  -0.16  NT 
B. Anti-D  b effector cells 
K4R Clones  BI0.BR  I  B10.A(4R) I  EL4/NY  EL4/Mar  RDM4 
-El  4.3  48  74  71  1.1 
-E4  2.8  44  81  79  4.2 
-E8  7.1  65  74  76  14 
-G6  -1.4  57  70  76  3.2 
* Effector cells: H-2Kb-specific CTL line KB5 and clones KB5-B  1 and C20 have been described  (8). H2Db-specific 
CTL clones (K.4R series) are from a BI 0.BR anti-B10.A  (4R) immunization.  Results shown are for an effector 
to target cell ratio of 2 to 1. Cell-mediated  cytotoxicity was performed and the percent specific release calculated 
as previously described  (8). 
* Con A-induced splenic blast cells. 
I Not tested. 
! Lipopolysaccharide-induced  splenic blast cells. 
all CTL clones derived from a B10.BR anti-B10.A (4R) immunization  (anti-D  b) 
lysed the EL4/Mar target cells as well as EL4/NY (Table II). 
Discussion 
Previous studies (1-3) have demonstrated that there is an association between 
MHC class I  heavy chains and/32m.  The observations that  the  Daudi cell line 
does not express any HLA class I  antigens  (4) and that  the R1  variant  is H-2- 
TL- (5, 6) due to defects in/32m synthesis suggest that/32m  is required for cell 
surface expression of class I  molecules. The data presented in this paper, using 
several criteria for detection of surface molecules, demonstrate that on a variant 
of the EL4 tumor line, EL4/Mar,  H-2D  b is expressed on the cell surface in the 
absence of detectable/32m.  In the human  MHC, results of sequential immuno- POTTER  ET  AL.  BRIEF  DEFINITIVE  REPORT  321 
precipitation of HLA molecules with monoclonal antibodies directed against the 
HLA heavy chain  or/32m  suggested that  a  subset of cell  surface  HLA heavy 
chains  is not associated with/32m  (11).  Thus,  the expression of H-2  b on EL4/ 
Mar  in  the  absence  of/32m,  while  novel  for  the  murine  system,  may not  be 
entirely unique for MHC class I antigens. 
The failure to express both K b and B2m on the cell surface could be due to a 
primary defect either in/32m or K  b synthesis; however, it is clear that if there is 
defect in B2m synthesis this does not affect D b expression. If the defect actually 
resides in K b heavy chain synthesis and O2m is produced, the failure to express 
/32m on the cell surface in association with H-2D  b raises the possibility that there 
is no association between D b and/32m, and that H-2D  b does not require/32m for 
membrane insertion. Alternatively, it may be that H-2D  b is inserted in association 
with B2m but the complex dissociates soon after the appearance of the antigen 
on the cell membrane.  In either case, it would seem that  the association of H- 
2D  b with/32m is more tenuous than that of other class I antigens. It is of interest 
to note that  in  contrast  to  K b,  K k, and  D d,  which  have two carbohydrate  side 
chains,  there  are  three  associated  with  the  D b molecule (12).  This  additional 
glycosylation site is on the C2 domain of the molecule, which has been suggested 
to be the/32m-binding region (13). In addition, precipitation with anti-D b brings 
down very little B2m compared with precipitation with anti-K b (14). It is therefore 
tempting to speculate that the third carbohydrate chain may replace/32m on D b. 
It is noteworthy that the/32m-free D b molecule expressed by EL4/Mar could 
be detected by the monoclonal antibody 28-14-8. The epitope recognized by this 
antibody has been mapped to the C2 domain of H-2L  d (15). As noted above, this 
is also the domain that has been suggested to be the/32m-binding domain (13). 
Whether  the additional  carbohydrate group present  in the C2 domains of the 
D b and L d molecules influences/32m association is not known. 
The results presented in this report may have some relevance to the attempts 
of groups studying the  nature  of the many class I  genes in  the murine  MHC. 
One assay involves the transfection of an unknown class I gene into LTK- cells, 
which are then evaluated for increased expression of/32m (16).  The failure of 
the transfected gene to cause an increase in/32m expression may be interpreted 
to mean that the gene is a  "pseudogene" or otherwise unable to direct synthesis 
of a cell surface class I protein. The fact that H-2D  b (this paper) and some human 
class I gene products (1 1) can be expressed on the cell surface without detectable 
/32m raises the possibility that other murine class I antigens may also exhibit this 
property. Therefore, a negative result in the/32m assay (16) must be interpreted 
with caution. 
Summary 
In this report we describe a variant of the C57BL/6 T  lymphoma EL4 (EL4/ 
Mar) which, in contrast to the parental cell line, expresses neither H-2K  b nor 32- 
microglobulin (32m) but which does express H-2D  b detectable by serology and 
by  alloreactive  cytotoxic  T  lymphocytes  (CTL).  This  observation  raises  the 
possibility that H-2D  b and perhaps other major histocompatibility complex class 
I molecules are normally not associated with 32m on the cell surface. In addition, 
this report is the first to indicate that alloreactive CTL can interact with a 32m- 
free class I antigen. 322  POTTER  ET  AL.  BRIEF  DEFINITIVE REPORT 
We are indebted to Drs.  U.  Hammerling, G. Hammerling, F.  W.  Shen,  T.  Hansen, S. 
Nathenson,  and  E.  Appe!la for  generously  providing  the  monoclonai  antibodies  and 
antisera used in this study. We also thank Ms.  Kathy Meringolo, M.  F.  Luciani, and M. 
Buferne  for  excellent  technical  help.  In  addition  we  thank  Ms.  Rosina  Passela  for 
secretarial assistance in the preparation of this manuscript. 
Received for publication  21 February 1984 and in revised form 19 March 1984. 
References 
1.  Grey, H. M., R. T. Hubo, S. M. Colon, M. D. Poulik, P. Creswell, T. Springer, M. 
Turner,  and J.  L.  Strominger.  1973.  The small subunit  of HL-A antigens  is /~2- 
microglobulin. J. Exp. Med.  138:1608. 
2.  Vitetta, E. S., J. W. Uhr, and E. A. Boyse. 1975. Association of a ¢~2microglobulin- 
like  subunit  with  H-2  and  TL  alloantigens  on  murine  thymocytes. J.  Immunol. 
114:252. 
3.  Michaleson,J., L. Flaherty, E. Vitetta, and M. D. Poulik. 1977. Molecular similarities 
between Qa-2 alloantigen and other gene products of the  17th chromosome of the 
mouse.J. Exp. Med.  145:1966. 
4.  Fellous, M., M. Kamoun, J. Wiels, J. Dausset, G. Clements, J. Zeuthen, and G. Klein. 
1977.  Induction of HLA expression in Daudi cells after cell fusion, lmmunogenetics. 
5:423. 
5.  Hyman, R., and V. Stallings. 1976. Characterization ofa TL-variant ofa homozygous 
TL  ÷ mouse lymphoma. Immunogenetics.  3:75. 
6.  Hyman, R., and V. Stallings. 1977. Analysis of hybrids between a H-2+TL  - lymphoma 
and an H-2÷TL  + lymphoma and its H-2-TL- variant subline. Immunogenetics.  4:171. 
7.  Gorer, P. A.  1950. Studies in antibody response of mice to tumour inoculation. Brit. 
J. Cancer. 4:372. 
8.  Albert,  F.,  M.  Buferne, C.  Boyer, and A.  M.  Schmitt-Verhulst.  1982.  Interactions 
between MHC-encoded products and cloned T  cells.  I. Fine specificity of induction 
of proliferation and lysis. Immunogenetics.  16:533. 
9.  Potter, T. A., M. A. Palladino, D. B. Wilson, and T. V. Rajan. 1983. Epitopes on H- 
2D  d somatic cell mutants recognized by cytotoxic T  cells. J. Exp. Med.  158:106 I. 
10.  Laemmli, V.  K.  1970.  Cleavage of structural  proteins during the assembly of the 
head of bacteriophage T4. Nature (Lond.).  227:680. 
11.  Rebai,  N.,  and B.  Malissen.  1983.  Structural  and genetic analyses of HLA class  I 
molecules using monoclonal xenoantibodies. Tissue Antigens.  22:107. 
12.  Kimball, E. S., W. L. Maloy, andJ. E. Coligan. 1981. Evidence for three carbohydrate 
prosthetic  groups  on  mouse  histocompatibility  antigens  H-2K  n and  H-2D  b.  Mol. 
Immunol.  18:677. 
13.  Yokoyama, K., and S. G. Nathenson.  1983. Intramolecular organization of class I H- 
2 MHC antigens: localization of the alloantigenic determinants and the O2m binding 
site to different regions of the H-2K  b glycoprotein. J. lmmunoI.  130:1419. 
14.  Maloy, W. L., G. Hammerling, S. G. Nathenson, andJ. E. Coligan. 1980. Comparison 
of alloantisera and hybridoma antibody for purification of the H-2D  b murine histo- 
compatibility antigen and preliminary molecular characterization of this antigen. J. 
Immunol. Methods.  37:287. 
15.  Evans, G. A., D. H. Margulies, B. Shykind, J. G. Seidman, and K. Ozato. 1982. Exon 
shuffling: mapping polymorphic determinants on hybrid mouse transplantation an- 
tigens. Nature (Lond.).  300:755. 
16.  Goodenow, R. S., M. McMillan, M. Nicolson, B. T. Sher, K. Eakle, N. Davidson, and 
L. Hood.  1982. Identification of the class I genes of the mouse major histocompati- 
bility complex by DNA-mediated gene transfer. Nature (Lond.).  300:231. 